Two Biotech Stocks on Takeover List?
Why These 2 Biotech Stocks Might Be Next On The Takeover List (IBD).
Acadia Pharmaceuticals (ACAD) and Neurocrine Biosciences (NBIX) stand...
Dyadic (DYAI) Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ
JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange...
Adding Mustang Bio (MBIO) $4.00 to Watchlist After Investor Presentation.
We met with management at Company-sponsored lunch at Ruth Chris in Boca Raton last week and we came away extremely enthusiastic about...
NanoVibronix (NAOV) $3.35, Gets $10.50 Price target from Dawson James.
Click here for report.
Dr Lindsay Rosenwald, Biography.
Wall Street Transcript Interview (2018)
IDB Bank Profile
Biography (2011) LR Facts*, below.
For...
Orchestra BioMed™ Announces Completion of $41 Million Financing.
November 15, 2018
Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and...
Immunomedics Chairman Buys $19 Million More in Stock.
(Barrons) Two weeks ago, B. Riley analyst Madhu Kumar gushed about Immunomedics, writing in a report that the biotech could have a “blockbuster cancer drug” in IMMU-132,...
Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.
NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage...
Added to Watch List $1.32, Dyadic Inc (DYAI) Announces $5 Million Stock Buyback.
CLICK TO VIEW REPORT
Adding Immunomedics (IMMU) $3.00 to Watch List.
Biotech Stock Review Initiates Coverage.
Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.
Latest article
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...
